This is a preview of subscription content, log in via an institution to check access.
Notes
2016 British pounds
National Institute for Health and Clinical Excellence
Reference
Khioe RFS, et al. Adjuvant Statin Therapy for Esophageal Adenocarcinoma: A Cost-Utility Analysis. PharmacoEconomics : 5 Dec 2017. Available from: URL: https://doi.org/10.1007/s40273-017-0594-1
Rights and permissions
About this article
Cite this article
Adjuvant statins cost saving in oesophageal adenocarcinoma. PharmacoEcon Outcomes News 793, 7 (2017). https://doi.org/10.1007/s40274-017-4567-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4567-6